OncoSec Medical Incorporated (ONCS) Upgraded by ValuEngine to Sell

ValuEngine upgraded shares of OncoSec Medical Incorporated (NASDAQ:ONCS) from a strong sell rating to a sell rating in a research note released on Thursday morning.

Separately, Maxim Group reissued a buy rating and set a $5.00 target price on shares of OncoSec Medical in a report on Friday, September 1st. One equities research analyst has rated the stock with a sell rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average target price of $5.33.

OncoSec Medical (NASDAQ ONCS) opened at $2.26 on Thursday. OncoSec Medical has a fifty-two week low of $0.88 and a fifty-two week high of $2.55.

OncoSec Medical (NASDAQ:ONCS) last issued its earnings results on Wednesday, October 25th. The biotechnology company reported ($0.28) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.23) by ($0.05). research analysts anticipate that OncoSec Medical will post -0.86 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://www.chaffeybreeze.com/2017/11/13/oncosec-medical-incorporated-oncs-upgraded-by-valuengine-to-sell.html.

OncoSec Medical Company Profile

OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company’s lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for OncoSec Medical (NASDAQ:ONCS)

Receive News & Ratings for OncoSec Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply